Mark Reed

Mark Reed has worked in the pharmaceutical industry for over 15 years. Mark began their career in 2004 as a Staff Scientist - Medicinal Chemistry at ICOS Corporation. In 2007, they moved to the Schering-Plough Research Institute, where they held the role of Senior Scientist. In 2008, they joined Treventis Corporation, where they held a number of roles, including Chief Scientific Officer (CSO), Senior Vice President of Research, Vice President of Therapeutics, and Director of Medicinal Chemistry. In 2011, they became an Assistant Professor at Dalhousie University.

Mark Reed attended the University of Sussex from 1996 to 2000, where they obtained a PhD in Organic Chemistry and Total Synthesis. Mark then attended Queen's University from 2000 to 2004, where they obtained a PDF in Organic Chemistry.